|
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
RECRUITINGPhase 2/3Sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Actively Recruiting
PhasePhase 2/3
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences
Started2022-10-10
Est. completion2025-09-30
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05504265
Summary
This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: * 18-75 years; * Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ; * Informed consent. Exclusion Criteria: * Has a history of cholecystitis or urolithiasis within 3 months; * Has a history of atherothrombosis (peripheral arterial disease), stroke, myocardial infarction; * With lung diseases, such as pneumonia, atelectasis, emphysema, pulmonary bullae, etc; * Preoperative cardiac function grade ≥ III or coronary artery stenosis; * Preoperative indwelling of a thoracic drainage tube; * Long-term heavy drinker(heavy drinking was defined as follows: for men, consuming more than 4 drinks on any day or more than 14 drinks per week; For women, consuming more than 3 drinks on any day or more than 7 drinks per week); * Opioid-tolerant patients(defined as those who have been taking, for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid); * With painful skin complications, such as rashes and blisters; * Conversion to open surgery; * The postoperative ventilation function was limited, or the duration of endotracheal intubation was more than 24h.
Conditions6
CancerEsophageal CancerNSAIDsOpioidPatient-controlled AnalgesiaPerioperative Analgesia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2/3
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences
Started2022-10-10
Est. completion2025-09-30
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05504265